Apexigen Obtains $20,000,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=17c4bf88-5ba8-4eed-b53c-663e862df74f - Date
8/6/2013 - Company Name
Apexigen - Mailing Address
863 Mitten Road Burlingame, CA 94010 - Company Description
Apexigen is a biopharmaceutical product development company advancing a pipeline of novel product candidates with the potential to address life-threatening and difficult to treat diseases. - Website
http://www.apexigen.com - Transaction Type
Venture Equity - Transaction Amount
$20,000,000 - Transaction Round
Series A - Proceeds Purposes
Financing proceeds will be used to work on an in-house cancer immunotherapy dubbed APX005. - M&A Terms
- Venture Investor
Amkey Ventures - Venture Investor
CDIB Bioscience - Venture Investor
Themes Investment Partners - Venture Investor
Sycamore Ventures
